1
Enquiry period
with 25.01.2022 15:13
to 27.01.2022 16:00
2
Bidding period
with 27.01.2022 16:00
to 31.01.2022 15:00
3
Auction
01.02.2022 11:23
4
Evaluation
5
Bids have been evaluated
Status Bids have been evaluated
Estimated value without VAT 840 MDL
Period of clarifications: 25 Jan 2022, 15:13 - 27 Jan 2022, 16:00
Submission of proposals: 27 Jan 2022, 16:00 - 31 Jan 2022, 15:00
Auction start date: 1 Feb 2022, 11:23

Supplier technical support:

(+373) 79999801

Lot 12 Ser monoclonal anti B (toliclon), flacon 5-10 ml
Information about customer
Fiscal code/IDNO
Address
2068, MOLDOVA, mun.Chişinău, mun.Chişinău, Alecu Russo 11/1
Web site
---
The contact person
Full name
Viorel Pocriciuc
Contact phone
+37322438237; +37360740772
Purchase data
Date created
25 Jan 2022, 15:10
Date modified
26 Jan 2022, 12:17
Estimated value (without VAT)
840 MDL
The minimum downward of the price
8,40 MDL
Achizitii.md ID
21050541
Type of procedure
Low cost purchase
Award criteria
The lowest price
Delivery address
2068, MOLDOVA, mun.Chişinău, mun.Chişinău, Alecu Russo 11/1
Contract period
1 Feb 2022 02:00 - 31 Dec 2022 02:00
List of positions
1)
Title
Lot 12 Ser monoclonal anti B (toliclon), flacon 5-10 ml CPV: 33140000-3 - Medical consumables
Quantity: 300.0
Unit of measurement: Centimetru cub; mililitru
Documents of the procurement procedure
anunt_de_participare_nou.docx
Bidding Documents
-
25.01.22 15:13
anexa nr.22 specificații tehnice.docx
Bidding Documents
-
25.01.22 15:13
anexa nr.24 model-contract.docx
Bidding Documents
-
25.01.22 15:13
anexa nr.23 specificații de preț.docx
Bidding Documents
-
25.01.22 15:13
duae_nou.doc
Bidding Documents
-
25.01.22 15:13
Qualification
Participant(s) name(s)
Normalized price
Status
1
Participant(s) name(s):

GBG-MLD SRL

Normalized price: 900 MDL
Status: Winner
Reason: Corespunde cerintelor solicitate
Qualification documents
Documents folder missing
Documents provided with the proposal
The history of the auction
View auction
Litigation
File an appeal
Unfortunately, questions can be asked only during the "Active" period.
Clarifications